Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 4 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Prognostication in inflammatory bowel disease.
Front Med (Lausanne). 2022 Oct 6;9:1025375. doi: 10.3389/fmed.2022.1025375. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 36275829
Free PMC article.
Review.
Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease.
Spencer EA, Bergstein S, Dolinger M, Pittman N, Kellar A, Dunkin D, Dubinsky MC.
Spencer EA, et al.
Inflamm Bowel Dis. 2023 Dec 22:izad300. doi: 10.1093/ibd/izad300. Online ahead of print.
Inflamm Bowel Dis. 2023.
PMID: 38134405
Item in Clipboard
Barriers to optimizing inflammatory bowel disease care in the United States.
Spencer EA, Abbasi S, Kayal M.
Spencer EA, et al.
Therap Adv Gastroenterol. 2023 May 5;16:17562848231169652. doi: 10.1177/17562848231169652. eCollection 2023.
Therap Adv Gastroenterol. 2023.
PMID: 37163167
Free PMC article.
Review.
Item in Clipboard
Choosing the Right Therapy at the Right Time for Pediatric Inflammatory Bowel Disease: Does Sequence Matter.
Spencer EA.
Spencer EA.
Gastroenterol Clin North Am. 2023 Sep;52(3):517-534. doi: 10.1016/j.gtc.2023.05.006.
Gastroenterol Clin North Am. 2023.
PMID: 37543397
Review.
Item in Clipboard
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Spencer EA, Dubinsky MC, Kamm MA, Chaparro M, Gionchetti P, Rizzello F, Gisbert JP, Wright EK, Schulberg JD, Hamilton AL, McGovern DPB, Dervieux T.
Spencer EA, et al.
Front Immunol. 2024 Jan 23;15:1342477. doi: 10.3389/fimmu.2024.1342477. eCollection 2024.
Front Immunol. 2024.
PMID: 38476237
Free PMC article.
Item in Clipboard
The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn's Disease with Infliximab.
Dubinsky MC, Rabizadeh S, Panetta JC, Spencer EA, Everts-van der Wind A, Dervieux T.
Dubinsky MC, et al.
Pharmaceutics. 2023 Sep 30;15(10):2408. doi: 10.3390/pharmaceutics15102408.
Pharmaceutics. 2023.
PMID: 37896168
Free PMC article.
Item in Clipboard
Cite
Cite